2-bromo-1-{3-[(1-methylethyl)oxy]phenyl}propan-1-one | 1198745-13-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-bromo-1-{3-[(1-methylethyl)oxy]phenyl}propan-1-one
• 英文别名: 2-Bromo-1-(3-propan-2-yloxyphenyl)propan-1-one；2-bromo-1-(3-propan-2-yloxyphenyl)propan-1-one
• CAS: 1198745-13-9
• 化学式: C₁₂H₁₅BrO₂
• 分子量: 271.154
• InChiKey: FAEFCPHURROUFH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-bromo-1-{3-[(1-methylethyl)oxy]phenyl}propan-1-one 、 2,2,2-三氟乙酰胺 在 potassium carbonate 作用下， 以 丙酮 为溶剂， 生成 2,2,2-trifluoro-N-(1-(3-isopropoxyphenyl)-1-oxopropan-2-yl)acetamide
  参考文献：
  名称：

  5-Aryl-imidazolin-2-ones as a scaffold for potent antioxidant and memory-improving activity

  摘要：

  A series of 5-phenyl-substituted-N-alkyl-imidazolin-2-ones with potent radical-scavenging activity and lipid peroxidation inhibitory activity was synthesized. Many of the compounds showed memory-improving effect in animal models independent of the inhibitory activity on lipid peroxidation. (c) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.12.064
• 作为产物：
  描述：

  3'-isopropoxypropiophenone 在 copper(ll) bromide 作用下， 以 乙酸乙酯 为溶剂， 反应 8.0h， 生成 2-bromo-1-{3-[(1-methylethyl)oxy]phenyl}propan-1-one
  参考文献：
  名称：

  NOVEL ISOXAZOLE DRIVATIVE

  摘要：

  揭示了一种由式(I)表示的化合物或其药学上可接受的盐，该化合物对GPR120具有激动活性，因此对于治疗糖尿病、肥胖或高脂血症是有用的。【在式(I)中，A代表可能被低烷氧基或类似物取代的苯基；13代表通过从苯环中去除两个氢原子而产生的二价基团，该苯环可能被卤素原子或类似物取代；X代表具有2至4个碳原子的低烷基基团或类似物，其中构成主链的碳原子可能被氧原子或类似物取代；Y代表氢原子或类似物。】

  公开号：

  US20110065739A1

文献信息

• NOVEL ISOXAZOLE DERIVATIVE
  申请人：MSD K.K.

  公开号：EP2298750A1

  公开（公告）日：2011-03-23

  Disclosed is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, which has an agonistic activity on GPR120 and is therefore useful for the treatment of diabetes, obesity or hyperlipemia. [In formula (I), the A represents a phenyl group which may be substituted by a lower alkoxy group or the like, or the like; the B represents a bivalent group produced by removing two hydrogen atoms from a benzene ring which may be substituted by a halogen atom or the like, or the like; X represents a lower alkylene group having 2 to 4 carbon atoms in its main chain or the like, wherein a carbon atom constituting the main chain may be substituted by an oxygen atom or the like; and Y represents a hydrogen atom or the like.]

  本发明公开了一种由式（I）代表的化合物或其药学上可接受的盐，该化合物对 GPR120 具有激动活性，因此可用于治疗糖尿病、肥胖症或高脂血症。式（I）中，A 代表苯基，可被低级烷氧基等取代；B 代表二价基团，通过从苯环中去除两个氢原子而产生，可被卤素原子等取代；X 代表低级亚烷基，其主链上有 2 至 4 个碳原子等，其中构成主链的一个碳原子可被氧原子等取代；Y 代表氢原子等。
• 5-Aryl-imidazolin-2-ones as a scaffold for potent antioxidant and memory-improving activity
  作者：Kazutoshi Watanabe、Yasuhiro Morinaka、Yoshio Hayashi、Masaki Shinoda、Hiroyoshi Nishi、Nobuko Fukushima、Toshiaki Watanabe、Akira Ishibashi、Satoshi Yuki、Masahiko Tanaka

  DOI：10.1016/j.bmcl.2007.12.064

  日期：2008.2

  A series of 5-phenyl-substituted-N-alkyl-imidazolin-2-ones with potent radical-scavenging activity and lipid peroxidation inhibitory activity was synthesized. Many of the compounds showed memory-improving effect in animal models independent of the inhibitory activity on lipid peroxidation. (c) 2008 Elsevier Ltd. All rights reserved.
• NOVEL ISOXAZOLE DRIVATIVE
  申请人：Ishikawa Makoto

  公开号：US20110065739A1

  公开（公告）日：2011-03-17

  Disclosed is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, which has an agonistic activity on GPR120 and is therefore useful for the treatment of diabetes, obesity or hyperlipemia. [In formula (I), the A represents a phenyl group which may be substituted by a lower alkoxy group or the like; the 13 represents a bivalent group produced by removing two hydrogen atoms from a benzene ring which may be substituted by a halogen atom or the like; X represents a lower alkylene group having 2 to 4 carbon atoms in its main chain or the like, wherein a carbon atom constituting the main chain may be substituted by an oxygen atom or the like; and Y represents a hydrogen atom or the like.]

  揭示了一种由式(I)表示的化合物或其药学上可接受的盐，该化合物对GPR120具有激动活性，因此对于治疗糖尿病、肥胖或高脂血症是有用的。【在式(I)中，A代表可能被低烷氧基或类似物取代的苯基；13代表通过从苯环中去除两个氢原子而产生的二价基团，该苯环可能被卤素原子或类似物取代；X代表具有2至4个碳原子的低烷基基团或类似物，其中构成主链的碳原子可能被氧原子或类似物取代；Y代表氢原子或类似物。】